RP-HPLC Method Development and Validation for Quantification of Fexofenadine in Pharmaceutical Products

Year 2021, Issue: 32, 1048 - 1053, 31.12.2021

Erten Akbel , İbrahim Bulduk

https://doi.org/10.31590/ejosat.1044758

Cited By: 1

Abstract

Fexofenadine belongs to the antihistamine family of drugs. It is used to treat seasonal allergic rhinitis symptoms. In this study, a rapid, simple and sensitive liquid chromatographic method for the quantitative determination of fexofenadine was optimized and validated. Agilent Extend C18 column was used to perform the separation. The optimum chromatographic separation was achieved by the mobile phase consist of acetonitrile and 20 mM KH2PO4 solution (pH 7.5) in 35:65 ratios respectively. The flow rate of 1.2 mL min-1 with a standard retention time of 3.5 min at a wavelength 220 nm was optimized. The developed method has been validated in terms of their linearity, specificity, precision, accuracy, limits of detection and quantification, and robustness as per I.C.H. guidelines. The developed method has shown excellent linearity, precision, and recovery. There were no spectral or chromatographic interferences from non-medicinal ingredients found. Within a concentration range of 10–60 g mL-1, the correlation coefficient was greater than 0.999. Low relative standard deviation values were obtained in the results of intra-day and inter-day precision tests. The method's accuracy ranged from 99.45 to 100.52 %. The present analytical method can be used to quantify fexofenadine in pharmaceutical preparations.

Keywords

Fexofenadine, analysis, method, validation

References

• O’Neil MJ: The Merck index: an encyclopedia of chemicals, drugs, and biological. 13 edition. Merck & Co., Inc., Whitehouse Station, NJ; 2001.
• Simpson K, Jarvis B: Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria. Drugs 2000, 59:301-321.
• Meeves SG, Appajosyula S: Efficacy and safety profile of fexofenadine HCL: A unique therapeutic option in H1-receptor antagonist treatment. J Allergy Clin Immunol 2003, 112:S69-S77.
• Rita Breier A, Nudelman NS, Steppe M, Schapoval EES: Isolation and structure elucidation of photodegradation products of fexofenadine. J Pharm Biomed Anal 2008, 46:250-257.
• Estelle F, Simons R: Antihistamines. In Allergy.. 2 edition. Edited by: Kaplan AP. Saunders WB Company, Philadelphia; 2002:834-863.
• Howarth PH: The choice of an H1-antihistamine for the 21st century. Clin Exp Allergy 2002, 2:18-25.
• https://www.drugs.com/mtm/fexofenadine. html
• Guo D, Zou J, Zhu Y, Lou S, Fan H, Qin Q: Measurement of fexofenadine concentration in micro-sample human plasma by a rapid and sensitive LC-MS/MS employing protein precipitation: application to a clinical pharmacokinetic study. Biomed Chromatogr 2010, 24:335-341.
• Arayne MS, Sultana N, Shehnaz H, Haider A: RP-HPLC method for the quantitative determination of fexofenadine hydrochloride in coated tablets and human serum. Med Chem Res 2011, 20:55-61.
• Konieczna L, Plenis A, Oledzka I, Kowalski P, Baczek T: Rapid RP-LC method with fluorescence detection for analysis of fexofenadine in human plasma. Chromatographia 2010, 71:1081-1086.
• Gazy AA, Mahgoub H, El-Yazbi FA, El-Sayed MA, Youssef RM: Determination of some histamine H1-receptor antagonists in dosage forms. J Pharm Biomed Anal 2002, 30:859-867.
• Ulavapalli KR, Sriramulu J, Mallu UR, Bobbarala V: Simultaneous determination of psuedoephedrine, fexofenadine and loratadine in pharmaceutical products using high resolution RP-HPLC method. J Pharm Res 2011, 4:1219-1221.
• Breier, A. R., Paim, C. S., Menegola, J., Steppe, M., Schapoval, E. E., & Schapoval, E. E. (2004). Development and validation of a liquid chromatographic method for fexofenadine hydrochloride in capsules. Journal of AOAC International, 87(5), 1093-1097.
• Karakuş S, Küçükgüzel I, Küçükgüzel SG: Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms. J Pharm Biomed Anal 2008, 46:295-302.
• Breier AR, Garcia SS, Jablonski A, Steppe M, Schapoval EES: Capillary electrophoresis method for fexofenadine hydrochloride in capsules. J AOAC Int 2005, 88:1059-1063.
• Mikus P, Valásková I, Havránek E: Determination of fexofenadine in tablets by capillary electrophoresis in free solution and in solution with cyclodextrins as analyte carriers. Drug Dev Ind Pharm 2005, 31:795-801.
• The United States Pharmacopeia, 31th edition. The Official monograph, The United States Pharmacopeial Convention, Rockville, MD, (2011); pp. 1186–1187.
• The British Pharmacopoeia, Her Majesty’s Stationery Office, London, (2010); pp. 46 –48.
• ICH. (2005). Q2 (R1), harmonized tripartite guideline, validation of analytical procedures: text and methodology, In Proceedings of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use.
• Center for Drug Evaluation and Research (CDER). (1994). Reviewer Guidance: Validation of Chromatographic Methods.